B.M.P. PHARMA TRAD (BMP.SG)
There is no Profile data available for BMP.SG.
B.M.P. PHARMA TRAD (BMP.SG) (BMP) - Net Assets
Latest net assets as of December 2024: €8.94 Million EUR
Based on the latest financial reports, B.M.P. PHARMA TRAD (BMP.SG) (BMP) has net assets worth €8.94 Million EUR as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€13.43 Million) and total liabilities (€4.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €8.94 Million |
| % of Total Assets | 66.53% |
| Annual Growth Rate | 5.97% |
| 5-Year Change | 46.56% |
| 10-Year Change | 73.61% |
| Growth Volatility | 13.29 |
B.M.P. PHARMA TRAD (BMP.SG) - Net Assets Trend (2013–2024)
This chart illustrates how B.M.P. PHARMA TRAD (BMP.SG)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for B.M.P. PHARMA TRAD (BMP.SG) (2013–2024)
The table below shows the annual net assets of B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €8.94 Million | +2.93% |
| 2023-12-31 | €8.68 Million | -14.73% |
| 2022-12-31 | €10.18 Million | +18.23% |
| 2021-12-31 | €8.61 Million | +41.23% |
| 2020-12-31 | €6.10 Million | +2.86% |
| 2019-12-31 | €5.93 Million | +5.51% |
| 2018-12-31 | €5.62 Million | +8.92% |
| 2017-12-31 | €5.16 Million | +0.32% |
| 2016-12-31 | €5.14 Million | -0.11% |
| 2015-12-31 | €5.15 Million | +8.08% |
| 2014-12-31 | €4.76 Million | +0.87% |
| 2013-12-31 | €4.72 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to B.M.P. PHARMA TRAD (BMP.SG)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 406676443.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €3.08 Million | 34.52% |
| Other Components | €5.85 Million | 65.48% |
| Total Equity | €8.94 Million | 100.00% |
B.M.P. PHARMA TRAD (BMP.SG) Competitors by Market Cap
The table below lists competitors of B.M.P. PHARMA TRAD (BMP.SG) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
EMBASSY OFFICE PARKS REIT UNITS
NSE:EMBASSY
|
$48.12K |
|
180060
KO:180060
|
$48.14K |
|
Atlas Honda Ltd
KAR:ATLH
|
$48.14K |
|
GABATHER AB (PUBL) SK-44
F:5J2
|
$48.15K |
|
KAPSCH (BZ6.SG)
STU:BZ6
|
$48.06K |
|
191600
KO:191600
|
$48.04K |
|
Balticon
WAR:BLT
|
$48.00K |
|
BQYL39
SA:BQYL39
|
$47.96K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in B.M.P. PHARMA TRAD (BMP.SG)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,681,305 to 8,935,863, a change of 254,558 (2.9%).
- Net income of 2,879,558 contributed positively to equity growth.
- Other factors decreased equity by 2,625,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.88 Million | +32.22% |
| Other Changes | €-2.63 Million | -29.38% |
| Total Change | €- | 2.93% |
Book Value vs Market Value Analysis
This analysis compares B.M.P. PHARMA TRAD (BMP.SG)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.00x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.19x to 3.00x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €0.98 | €5.10 | x |
| 2018-12-31 | €1.07 | €5.10 | x |
| 2019-12-31 | €1.13 | €5.10 | x |
| 2020-12-31 | €1.16 | €5.10 | x |
| 2021-12-31 | €1.64 | €5.10 | x |
| 2022-12-31 | €1.94 | €5.10 | x |
| 2023-12-31 | €1.65 | €5.10 | x |
| 2024-12-31 | €1.70 | €5.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently B.M.P. PHARMA TRAD (BMP.SG) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 32.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 179439.64%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.50x
- Recent ROE (32.22%) is above the historical average (11.78%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 6.80% | 10700.00% | 0.00x | 1.04x | €-151.10K |
| 2014 | 0.86% | 4100.00% | 0.00x | 1.03x | €-435.20K |
| 2015 | 7.48% | 3850.00% | 0.00x | 1.05x | €-129.70K |
| 2016 | -0.12% | -144.60% | 0.00x | 1.06x | €-520.21K |
| 2017 | 0.32% | 937.82% | 0.00x | 1.08x | €-499.37K |
| 2018 | 8.19% | 6404.23% | 0.00x | 1.07x | €-101.51K |
| 2019 | 5.22% | 27763.22% | 0.00x | 1.08x | €-283.39K |
| 2020 | 2.79% | 17000.00% | 0.00x | 1.14x | €-439.70K |
| 2021 | 30.41% | 58819.09% | 0.00x | 1.14x | €1.76 Million |
| 2022 | 15.42% | 95665.46% | 0.00x | 1.21x | €551.61K |
| 2023 | 31.71% | 4894360.07% | 0.00x | 1.40x | €1.88 Million |
| 2024 | 32.22% | 179439.64% | 0.00x | 1.50x | €1.99 Million |
Industry Comparison
This section compares B.M.P. PHARMA TRAD (BMP.SG)'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| B.M.P. PHARMA TRAD (BMP.SG) (BMP) | €8.94 Million | 6.80% | 0.50x | $48.09K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |